CHRM3 and neoplasm: Key pathways activated in neoplasias by BAs are regulated by nuclear receptors, FXR, CAR, SHP, PXR, LXR and VDR and other membrane receptors such as S1PR2, TGR5, CHRM2 and CHRM3.